Surveillance status and recent data for Mycoplasma pneumoniae infections in the European Union and European Economic Area, January 2012.
In January 2012, the European Centre for Disease Prevention and Control (ECDC) conducted an email based survey of European Union and European Economic Area countries to describe the existing surveillance activities for Mycoplasma pneumoniae infections, recent findings and existence of clinical guidelines for the treatment of M. pneumoniae infection. Of the 20 countries that participated in the survey, seven reported increases in M. pneumoniae infections observed during the autumn and winter of 2011.
European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden. annick.lenglet@ecdc.europa.eu
A
A
Lenglet
Z
Z
Herrador
A P
AP
Magiorakos
K
K
Leitmeyer
D
D
Coulombier
D000900:Anti-Bacterial Agents / Q000600:supply & distribution / Q000627:therapeutic use; D058872:Epidemics; D004917:Erythromycin / Q000600:supply & distribution / Q000627:therapeutic use; D005060:Europe / Q000453:epidemiology; D005062:European Union; D006306:Health Surveys; D006801:Humans; D015994:Incidence; D011019:Pneumonia, Mycoplasma / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D011159:Population Surveillance / Q000379:methods; D017410:Practice Guidelines as Topic; D011795:Surveys and Questionnaires
D000900:Anti-Bacterial Agents; D004917:Erythromycin